Vietnam · Delayed Price · Currency is VND HNX:MED Statistics
Total Valuation
HNX:MED has a market cap or net worth of VND 228.34 billion. The enterprise value is 233.80 billion.
| Market Cap | 228.34B |
| Enterprise Value | 233.80B |
Important Dates
The next estimated earnings date is Friday, January 22, 2027.
| Earnings Date | Jan 22, 2027 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
HNX:MED has 12.41 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 12.41M |
| Shares Outstanding | 12.41M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 65.48% |
| Owned by Institutions (%) | n/a |
| Float | 4.28M |
Valuation Ratios
The trailing PE ratio is 8.80.
| PE Ratio | 8.80 |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | 11.54 |
| P/OCF Ratio | 8.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.51, with an EV/FCF ratio of 11.82.
| EV / Earnings | 9.01 |
| EV / Sales | 0.54 |
| EV / EBITDA | 5.51 |
| EV / EBIT | 6.55 |
| EV / FCF | 11.82 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.70 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | 1.71 |
| Interest Coverage | 12.14 |
Financial Efficiency
Return on equity (ROE) is 7.71% and return on invested capital (ROIC) is 7.83%.
| Return on Equity (ROE) | 7.71% |
| Return on Assets (ROA) | 4.86% |
| Return on Invested Capital (ROIC) | 7.83% |
| Return on Capital Employed (ROCE) | 10.26% |
| Weighted Average Cost of Capital (WACC) | 4.36% |
| Revenue Per Employee | 1.40B |
| Profits Per Employee | 83.72M |
| Employee Count | 310 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 3.60 |
Taxes
In the past 12 months, HNX:MED has paid 7.35 billion in taxes.
| Income Tax | 7.35B |
| Effective Tax Rate | 22.07% |
Stock Price Statistics
The stock price has decreased by -18.58% in the last 52 weeks. The beta is -0.07, so HNX:MED's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | -18.58% |
| 50-Day Moving Average | 23,882.00 |
| 200-Day Moving Average | 24,448.00 |
| Relative Strength Index (RSI) | 30.35 |
| Average Volume (20 Days) | 2,376 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HNX:MED had revenue of VND 434.97 billion and earned 25.95 billion in profits. Earnings per share was 2,090.74.
| Revenue | 434.97B |
| Gross Profit | 98.70B |
| Operating Income | 35.72B |
| Pretax Income | 33.30B |
| Net Income | 25.95B |
| EBITDA | 42.47B |
| EBIT | 35.72B |
| Earnings Per Share (EPS) | 2,090.74 |
Balance Sheet
The company has 28.30 billion in cash and 33.75 billion in debt, with a net cash position of -5.45 billion or -439.44 per share.
| Cash & Cash Equivalents | 28.30B |
| Total Debt | 33.75B |
| Net Cash | -5.45B |
| Net Cash Per Share | -439.44 |
| Equity (Book Value) | 348.25B |
| Book Value Per Share | 28,061.69 |
| Working Capital | 78.87B |
Cash Flow
In the last 12 months, operating cash flow was 28.16 billion and capital expenditures -8.38 billion, giving a free cash flow of 19.78 billion.
| Operating Cash Flow | 28.16B |
| Capital Expenditures | -8.38B |
| Depreciation & Amortization | 6.75B |
| Net Borrowing | -16.11B |
| Free Cash Flow | 19.78B |
| FCF Per Share | 1,593.87 |
Margins
Gross margin is 22.69%, with operating and profit margins of 8.21% and 5.97%.
| Gross Margin | 22.69% |
| Operating Margin | 8.21% |
| Pretax Margin | 7.66% |
| Profit Margin | 5.97% |
| EBITDA Margin | 9.76% |
| EBIT Margin | 8.21% |
| FCF Margin | 4.55% |
Dividends & Yields
This stock pays an annual dividend of 900.00, which amounts to a dividend yield of 4.89%.
| Dividend Per Share | 900.00 |
| Dividend Yield | 4.89% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 19.86% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.07% |
| Shareholder Yield | 4.82% |
| Earnings Yield | 11.36% |
| FCF Yield | 8.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HNX:MED has an Altman Z-Score of 3.24 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.24 |
| Piotroski F-Score | 6 |